NASDAQ
Goldenwell Biotech, Inc. (GWLL) has a current ratio of 120.53x as of Tuesday, May 26, 2026. This represents a 179.30% increase compared to its 12-month average of 43.16x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.